drugset / Trial / NCT04756206

Role of Dutasteride in Treatment of Chronic Prostatitis

NCT04756206

Phase 2/3 Completed 50 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindTreatment

Summary

this placebo controlled study aims to evaluate the efficacy of Dutasteride in the management of Chronic prostatitis type 3.

Timeline

Start
2019-01-01
Primary completion
2020-01-01
Completion
2020-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dutasteride Small molecule 0.5 mg